PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO

Author's Avatar
May 13, 2022

%3Cb%3EPAVmed+Inc.%3C%2Fb%3E (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company, and its majority-owned subsidiary %3Cb%3ELucid+Diagnostics+Inc.%3C%2Fb%3E (Nasdaq: LUCD) (“Lucid”), a commercial-stage cancer prevention medical diagnostics company, today announced that PAVmed and Lucid Chairman & Chief Executive Officer Lishan+Aklog%2C+M.D. was selected as one of the Top 50 Healthcare Technology CEOs of 2022 by %3Cb%3E%3Ci%3EThe+Healthcare+Technology+Report%3C%2Fi%3E%3C%2Fb%3E.